Page last updated: 2024-08-22

pyrvinium and Ovarian Neoplasms

pyrvinium has been researched along with Ovarian Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hu, P; Wang, W; Zhang, C; Zhang, S; Zhang, Z	1

Other Studies

1 other study(ies) available for pyrvinium and Ovarian Neoplasms

Article	Year
Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy. Medical science monitor : international medical journal of experimental and clinical research, 2017, Jan-16, Volume: 23 Topics: Animals; Anthelmintics; Antineoplastic Agents; Apoptosis; beta Catenin; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Lithium Chloride; Mice, SCID; Ovarian Neoplasms; Paclitaxel; Pyrvinium Compounds; Wnt Signaling Pathway	2017

Article

Year

Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy.

Medical science monitor : international medical journal of experimental and clinical research, 2017, Jan-16, Volume: 23

Topics: Animals; Anthelmintics; Antineoplastic Agents; Apoptosis; beta Catenin; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Lithium Chloride; Mice, SCID; Ovarian Neoplasms; Paclitaxel; Pyrvinium Compounds; Wnt Signaling Pathway

2017